Australian University Rankings Guide

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine (ERA Journal)

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine issns are issn1: 1535-2811 issn2: 1535-282X.

The fields covered by Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine as part of the evaluation of Australian university research excellence are:

Cardiorespiratory Medicine and Haematology Research Rankings (Sub-Field)

Clinical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Cardiorespiratory Medicine and Haematology field include:

- ACC Cardiosource Review Journal
- Canadian Journal of Respiratory Therapy
- Cardiology
- Circulation: Cardiovascular Genetics
- Clinical Cardiology (Hoboken): an indexed and peer-reviewed journal for advances in the treatment of cardiovascular disease
- Clinical and Applied Thrombosis / Hemostasis
- Current Opinion in Lipidology
- Current Respiratory Medicine Reviews
- European Heart Journal: Acute Cardiovascular Care
- European Journal of Preventative Cardiology
- Expert Review of Hematology
- International Journal of Hematology
- Journal of Electrocardiology
- Pathogens and Disease
- Vascular Cell


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4